SIALORRHEA
Clinical trials for SIALORRHEA explained in plain language.
Never miss a new study
Get alerted when new SIALORRHEA trials appear
Sign up with your email to follow new studies for SIALORRHEA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection offers hope for chronic drooling
Symptom relief CompletedThis study tested a drug called MYOBLOC, injected into the salivary glands, to safely reduce drooling in 187 adults who had troublesome drooling for at least 3 months. The treatment decreased saliva production and improved symptoms compared to a placebo. It is designed to ease a …
Matched conditions: SIALORRHEA
Phase: PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief
Last updated May 02, 2026 05:02 UTC
-
New drooling treatment shows promise in year-long trial
Symptom relief CompletedThis study tested the safety and effectiveness of repeated MYOBLOC injections over one year in 187 adults with troublesome drooling caused by conditions like Parkinson's disease, stroke, or ALS. Participants received up to four treatment sessions, and researchers monitored side e…
Matched conditions: SIALORRHEA
Phase: PHASE3 • Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC • Aim: Symptom relief
Last updated Apr 23, 2026 12:45 UTC